BIOMARKERS FOR DIAGNOSIS OF HEART FAILURE IN DIABETES

View Recording

BIOMARKERS FOR DIAGNOSIS OF HEART FAILURE in Diabetes

Wednesday, September 20, 2023

Moderators

Alexander Fleming, MD
Founder and Executive Chairman
Kinexum, Harpers Ferry, WV

David Sacks M.B., Ch.B., FRCPath
Senior Investigator and Chief of Clinical Chemistry
National Institutes of Health, Bethesda, MD

9:00

Introduction

9:05

The Four Stages of Heart Failure

James Januzzi, MD
Director of Heart Failure and Biomarker Trials at the Baim Institute for Clinical Research
Massachusetts General Hospital, Harvard Medical School, Boston, MA

9:20

Diabetes and Heart Failure

Rodica Pop Busui, MD, PhD
American Diabetes Association President of Medicine and Science, Vice Chair of Clinical Research in Department of Internal Medicine
University of Michigan, Ann Arbor, MI

9:35

Natriuretic Peptide and Troponin for Diagnosing Heart Failure in Diabetes

Ibrahim A. Hashim, MSc, PhD
Chief of Clinical Pathology
UT Southwestern, Dallas, TX

9:50

Emerging Composite and Investigational Biomarkers for Diagnosing Heart Failure

Alan H.B. Wu, PhD
Chief of Clinical Chemistry and Toxicology
University of California, San Francisco, San Francisco, CA

10:05

Prevention of Heart Failure Progression (including case studies)

Ambarish Pandey, MD
Medical Director of Heart Failure with Preserved Ejection Fraction Program
UT Southwestern, Dallas, TX

10:20

Q&A

10:30

Conclude - End of Meeting

Program